E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma

Urologia Internationalis

Volumn 81, Issue 3, 2008, Pages 320-324

  Shi, Benkang ^a   Laudon, Vincent ^c   Yu, Shengqiang ^b   Dong, Dexin ^a   Zhu, Yaofeng ^a   Xu, Zhishun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c HARTFORD HOSPITAL   (United States)

Author keywords

Bladder neoplasms; E cadherins; Transitional cell carcinoma; Urine

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; TUMOR VOLUME; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 54249165046     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151412     Document Type: Article

References (17)

1. Bongiorno PF, al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, et al: E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 1995;71:166-172.
2. Takeichi M: Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990;59:237-252.
3. Takeichi M: Cadherin cell adhesion receptions as a morphorgentic regulator. Science 1991;251:1451-1455.
4. Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, et al: E-cadherin expression predicts clinical outcome in carcinoma in situ of urinary bladder. Urology 2001;57:60-65.
5. Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA Jr, et al: E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term follow up. J Urol 2001;165:1473-1479.
6. Vleminckx K, Vakaet L, Mareel M, Fiers W, van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion-suppressor role. Cell 1991;66:107-119.
7. Durken GC, Brotherick I, Mellon JK: The impact of transurethral resection of bladder tumor on serum levels of soluble E-cadherin. BJU Int 1999;83:424-428.
8. Banks RE, Porter WH, Whelan P, Smith PH, Selby PJ: Soluble forms of the adhesion molecule E-cadherin in urine. J Clin Pathol 1995;48:179-180.
9. Rimm DL, Morrow JS: Molecular cloning of human E-cadherin suggests a novel subdivision of the cadherin superfamily. Biochem Biophys Res Commun 1994;200:1754-1761.
10. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, et al: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cell. J Cell Biol 1991;13:173-185.
11. Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I: Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994;69:580-585.
12. Griffiths TRL, Brotherick I, Bishop RI, White MD, McKenna DM, Home CH, et al: Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer 1996;74:579-584.
13. Lee SE, Byun SS, Park YH, Chang IH, Kim YJ, Hong SK: Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract. Urol Int 2006;77:22-26.
14. Rebel JM, Thijssen CD, Vermey M, Delouvee A, Zwarthoff EC, Van der Kwast TH: E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cells. Cancer Res 1994;54:5488-5492.
15. Matsumoto K, Shariat SF, Casella R, Wheeler TM, Slawin KM, Lerner SP: Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy. J Urol 2003;170:2248-2252.
16. Shariat SF, Matsumoto K, Casella R, Jian W, Lerner SP: Urinary level of soluble E-cadherin in the detection of transitional cell carcinoma of the urinary bladder. Eur Urol 2005;48:69-76.
17. Protheroe AS, Banks RE, Mzimba M, Porter WH, Southgate J, Singh PN, et al: Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer. Br J Cancer 1999;80:273-278.